Subviral Agents
Retroviruses
Pulmonary Tuberculosis IV
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jan 13, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Gayle S Tatz1, Eleanor A Ochodo2,3, Tilly Fox4
1Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
Molnupiravir, an oral antiviral for COVID-19, shows little to no difference in mortality or hospitalisation for outpatients. Its clinical relevance for viral clearance is unclear, with no significant impact on adverse events.
Area of Science:
Background:
Conclusions: